Theodore James Cory
Overview
Explore the profile of Theodore James Cory including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Williams V, Cory T
Expert Opin Pharmacother
. 2024 Dec;
26(1):9-15.
PMID: 39651697
Introduction: HIV is a global disease affecting millions of people. While treatments have improved over the past decades, treatment failure remains a significant issue for treatment experienced patients. Doravirine/islatravir is...
2.
Branch C, Parson-Martinez J, Cory T
Expert Opin Drug Metab Toxicol
. 2024 Sep;
21(1):15-27.
PMID: 39305240
Introduction: Coadministration of antiretrovirals and anti-cancer medications may present many complex clinical scenarios. This is characterized by the potential for drug-drug interactions (DDIs) and the challenges that arise in patient...
3.
Doan J, Brunzo-Hager S, Satterly B, Cory T
Expert Opin Pharmacother
. 2024 Jan;
24(18):1949-1956.
PMID: 38164956
Introduction: Treatment for people with HIV/AIDS has radically evolved since the introduction of the first antiretrovirals. One newly approved antiretroviral is lenacapavir, which targets the viral capsid. Lenacapavir is currently...
4.
Ellis C, Inaba K, Van de Vuurst C, Ghrayeb A, Cory T
Expert Opin Drug Metab Toxicol
. 2023 Oct;
19(11):795-806.
PMID: 37800561
Introduction: With new effective treatments for SARS-CoV-2, patient outcomes have greatly improved. However, new medications bring a risk of drug interactions with other medications. People living with HIV (PLWH) are...
5.
Pence B, Zhang Y, Antwi I, Cory T
NeuroImmune Pharm Ther
. 2022 Dec;
1(1):37-42.
PMID: 36534613
SARS-CoV-2 has, since its emergence in 2019, become a global pandemic. Disease outcomes are worsened in older patients who are infected. The causes for this is multifactorial, but one potential...
6.
Qazzaz H, Parganas C, Cory T
Expert Opin Pharmacother
. 2022 Sep;
23(13):1485-1495.
PMID: 36124818
Introduction: HIV is a global disease that has seen significant improvements in care over the past decades. Despite improvements, treatments for maintaining suppression are complex for patients and include two...
7.
Kalada W, Cory T
Curr HIV Res
. 2021 Dec;
20(2):102-110.
PMID: 34961449
Purpose Of Review: There have been significant developments in the treatment of people living with HIV-1/AIDS with current antiretroviral therapies; however, these developments have not been able to achieve a...
8.
Balatow P, Sandlin A, Cory T
Expert Opin Pharmacother
. 2021 Jun;
22(14):1839-1846.
PMID: 34157923
: Hepatitis C (HCV) is viral disease with a global impact. Over the last 10 years, the treatment of this disease has evolved. Treatment guidelines have evolved to adopt new...
9.
Kumar A, Kodidela S, Tadrous E, Cory T, Walker C, Smith A, et al.
Viruses
. 2020 Aug;
12(8).
PMID: 32823684
Extracellular vesicles (EVs) have shown their potential as a carrier of molecular information, and they have been involved in physiological functions and diseases caused by viral infections. Virus-infected cells secrete...